September 29, 2020 – ReST Therapeutics

First Results on FENM published in International Journal of Neuropsychopharmacology

Gilles Rubinstenn - 29 September 2020 - 7:41 pm

FENM appeared as a potent neuroprotective drug in an AD model,[…]